The Lifespan/Tufts/Brown CFAR was established in 1998 as a collaboration between Brown University and Tufts University and their affiliated hospitals. Since the Initial CFAR award in 1998, we have successfully competed for two renewals, and met our stated benchmarks and milestones throughout the 12 years since the Initial award. We have revised our goals as the epidemic and its treatment have evolved, and steadily increased the interdisciplinary research essential to further progress in this area. This CFAR serves as the basis for extensive collaborative, interdisciplinary research among the CFAR members, and has served as the leading force in developing and supporting relevant new initiatives. This application emphasizes the return on investment of funding cross-disciplinary HIV research throughout Brown and Tufts Universities, their affiliated hospitals, and partner institutions in the developing world. In accordance with directives in the NIH CFAR PAR, we have developed a multidisciplinary environment that supports basic, clinical, epidemiologic, behavioral and translational research in the detection, prevention, and treatment of HIV infection and AIDS. This application emphasizes our progress toward this mission over the past four years, and its proposed activities over the next five years. If this application proves to be successful. Looking ahead, we Intend to further emphasize multi-institutional, cross-disciplinary studies related to HIV/AIDS both in New England and In Sub-Saharan Africa and Asia, with continuing support for our established CFAR Scientific Programs In International HIV/AIDS and in Prisoner Health and Human Rights for cross-disciplinary work In our Scientific Working Groups related to neurocognitive aspects of HIV and its treatment, cardiovascular and metabolic consequences of HIV and antiretroviral therapy In our aging population of persons living with HIV, and further multidisciplinary studies of the consequences of alcohol and other substances of abuse on HIV acquisition and response to treatment.

Public Health Relevance

Despite advances In HIV/AIDS treatment and prevention, the disease continues to ravage many lives. Our CFARs ultimate goal is to Improve the lives of people living with HIV and prevent new Infections by serving as a basis for extensive collaborative, multi and Interdisciplinary research. The development of junior investigators within the field is crucial to stemming this epidemic.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI042853-15
Application #
8281964
Study Section
Special Emphasis Panel (ZAI1-RRS-A (J1))
Program Officer
Namkung, Ann S
Project Start
1998-09-01
Project End
2017-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
15
Fiscal Year
2012
Total Cost
$1,965,883
Indirect Cost
$442,622
Name
Miriam Hospital
Department
Type
DUNS #
063902704
City
Providence
State
RI
Country
United States
Zip Code
02906
Lee, Hana; Wu, Xiaotian K; Genberg, Becky L et al. (2018) Beyond binary retention in HIV care: predictors of the dynamic processes of patient engagement, disengagement, and re-entry into care in a US clinical cohort. AIDS 32:2217-2225
Whiteley, Laura B; Brown, Larry K; Curtis, Virginia et al. (2018) Publicly Available Internet Content as a HIV/STI Prevention Intervention for Urban Youth. J Prim Prev :
Sackey, Joachim; Zhang, Fang Fang; Rogers, Beatrice et al. (2018) Food security and dietary diversity are associated with health related quality of life after 6 months of follow up among people living with HIV in Accra, Ghana. AIDS Care 30:1567-1571
Rodriguez, Carla V; Rubenstein, Kevin B; Linas, Benjamin et al. (2018) Increasing hepatitis C screening in a large integrated health system: science and policy in concert. Am J Manag Care 24:e134-e140
Olney, Jack J; Eaton, Jeffrey W; Braitstein, Paula et al. (2018) Optimal timing of HIV home-based counselling and testing rounds in Western Kenya. J Int AIDS Soc 21:e25142
Gnatienko, Natalia; Freiberg, Matthew S; Blokhina, Elena et al. (2018) Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia. HIV Clin Trials 19:101-111
Brinkley-Rubinstein, Lauren; McKenzie, Michelle; Macmadu, Alexandria et al. (2018) A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release. Drug Alcohol Depend 184:57-63
Sam, Soya S; Caliendo, Angela M; Ingersoll, Jessica et al. (2018) Performance evaluation of the Aptima HSV-1 and 2 assay for the detection of HSV in cutaneous and mucocutaneous lesion specimens. J Clin Virol 99-100:1-4
Lally, Michelle A; van den Berg, Jacob J; Westfall, Andrew O et al. (2018) HIV Continuum of Care for Youth in the United States. J Acquir Immune Defic Syndr 77:110-117
Schechter-Perkins, Elissa M; Miller, Nancy S; Hall, Jon et al. (2018) Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program. Acad Emerg Med :

Showing the most recent 10 out of 806 publications